Global Oligonucleotide Synthesis Market Size was valued nearly USD 1.5 billion by 2017 and is estimated to reach up to USD xx.xx billion by 2025. According to latest study conducted by our analysts and industry experts, the global market is expected to grow at a CAGR of 13.7% during the forecast period, i.e. 2017-2025 owing to the rapidly growing research and development activities in the pharma and biotech sectors and the growing demand for innovative diagnostic and therapeutic techniques. Oligonucleotide synthesis is an integral part of several ongoing genetic research studies. The major and emerging oligonucleotides key players are investing and expanding their businesses through collaboration with pharmaceutical manufacturers.

Global Market Growth Opportunities (Revenue, Growth) By 2017-2025

This global market study report analysis offers in-depth insights, revenue details, and other vital information regarding the global oligonucleotide synthesis market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2025. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global oligonucleotide synthesis market report has been segmented on the basis of type, application, and region. It includes the estimation of the market size, in terms of value, with respect to 4 main geographies, namely, North America, Europe, APAC, and RoW.

Market Dynamic

According to the new market research study on " Global Oligonucleotide Synthesis Market Size, By Product (Probe, Linkers, Adaptor, Drugs, Reagent, Equipment); Type (Custom, Pre design); Application (PCR, DNA, RNAi, Research, Therapeutic); End User (Hospital, Pharmaceutical, Biotechnology); Regional Analysis (North America - U.S, Canada, Other) (Asia-Pacific -India, Japan, China, Australia, Other) (Europe - UK, Russia, France, Brazil, Other) (Middle East and Africa) - Global Industry Insights, Trends and Forecast, 2017-2025. The global oligonucleotide synthesis market showed crucial growth in the recent years and is anticipated to witness a steep rise by generating an estimated revenue of US$ xx.xx over the forecast period. According to latest study conducted by our analysts and industry experts, the global market is expected to grow at a CAGR of 13.7% during the forecast period that is 2017-2025. The study identifies and analyzes the market dynamics, such as drivers, restraints, opportunities, and industry-specific challenges pertaining to the market. It also profiles key players operating in the oligonucleotide synthesis industry. The growth of this market is driven by the factors such as the growing demand across industries, emerging sectors, demanding regions and countries, safety standards, and growing productivity owing to improved technological advancement.  

Segment Analysis

The objective of this market study is to analyze, define, describe, and forecast the hybrid train market basis on platform, product, position, propulsion, distribution channel, operating speed, application and region.

Products Insights: Based on products, the oligonucleotide synthesis market has been divided into probe, linkers, adaptor, drugs, reagent, and equipment. The Oligonucleotide-based drugs segment in oligonucleotide synthesis is calculated to be the largest and fastest growing in the market in 2018 due to the increasing demand for oligonucleotide-based drugs and the influx of new customers in the oligo drug development arena.      

Application Insights: The oligonucleotide synthesis market, by application, is classified into PCR, DNA, RNAi, Research, and Therapeutic. The PCR segment is projected to boost product demand in the global market over the forecast period due to increasing high investment in the oligonucleotides-based therapeutics, including antisense therapeutics, DNA vaccines, and anti-viral agents, in various phases of clinical development has allowed PCR primers to calculate the largest revenue share in the market. 

End-use Insights: Based on end-use, the oligonucleotide synthesis market has been divided into hospital, academic research institutes, diagnostic laboratories, pharmaceutical and biotechnology. The hospital segment is projected to hold highest market share in 2018 and is estimated to grow at healthy CAGR rate during the forecast period in terms of revenue due to pharmaceutical and biotechnology companies are mainly focused on seeking alternative approaches for disease treatment.      

Regional Analysis

The global oligonucleotide synthesis market is divided into regions that are North America - U.S, Canada, Other; Asia-Pacific -India, Japan, China, Australia, Other; Europe - UK, Russia, France, Brazil, Other; Middle East and Africa. Every region analysis details in sense of growth, revenue, volume, challenges, and opportunities with the regional and global key players. The North America market is anticipated to show positive growth outlook due to technological advancement, high investment in research and development, government support and well-developed infrastructure are factors will boost the market growth and demand during the forecast period. Presence of innovators and key players in U.S. has resulted in higher penetration of products in the market. Asia Pacific market is projected to drive the market demand over the forecast period, the market majorly driven by rapid progress in genomics studies and the healthcare sector. The emerging economies such as China and India are considered as most attractive destination for key players in the terms of expansion and growth opportunities.  Additionally, the changing economic scenario, high investments in healthcare, research and development activities in healthcare industry, and genetics, has boosted the global players to enter the Asia Pacific market, that factors are propel growth of market.

Global Oligonucleotide Synthesis Market Size, Share Analysis By Region 2017

Global Oligonucleotide Synthesis Market Study Objective

1. To forecast the market size of oligonucleotide synthesis market, along with describing and defining the market, in terms of volume and revenue.

2. Market analysis and forecast of oligonucleotide synthesis market on the basis of region, substrate and application or end-use industry.

3. To analyze and elaborate significant factors that will have major impact on the growth of oligonucleotide synthesis market, such as drivers, restraints, challenges and opportunities.

4. Regional analysis of oligonucleotide synthesis market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa and Asia Pacific.

5. Strategic analysis of micromarkets, in terms of individual prospects, opportunities, growth trends and their involvement in overall market.

6. To provide detailed analysis of competitive and strategic developments in the oligonucleotide synthesis market like new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

7. Analysis of market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

8. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

Bottom-up and top-down are two main approaches that were taken into account to anticipate and validate the market size of oligonucleotide synthesis market, and to reach the anticipated market size of several dependent submarkets. The research and study involved massive utilization of secondary data sources, several directories, private and government websites, and authentic databases, to collect or gather market-oriented as well as technical information for the study of oligonucleotide synthesis market commercially.

Key Players

The major kay players in the oligonucleotide synthesis market which will contribute healthy growth in regional and global market over the forecast period that key players are Agilent Technologies, Inc., ATDBio Ltd., Bio-Synthesis, Inc., BioAutomation Corporation, LGC Biosearch Technologies, Eurofins Genomics, Eurogentec, GeneDesign, Inc., GE Healthcare, GenScript, Inc., Integrated DNA Technologies, Nitto Denko Avecia, Inc., Sarepta Therapeutics, Thermo Fisher Scientific, Inc., TriLink BioTechnologies, and Sigma-Aldrich Corporation.  

Global Oligonucleotide Synthesis Market Study Report Offer You!

The global market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end user & applications, provisions, livestock, commodities and industry economics analysis, future growth and forecast. The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.